Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Business Tribune.
Press releases published on August 8, 2025
Barnes & Noble Education Receives NYSE Notice Regarding Delayed 10-K Filing
GlobeNewswire
·
August 8, 2025
BASKING RIDGE, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 4, 2025, Barnes …
Lost Money on iRobot Corporation(IRBT)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 6, 2025 in Altimmune Lawsuit – ALT
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Fiserv, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights – FI
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Investors in Hims & Hers Health, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
NI Holdings, Inc. Reports Results for Second Quarter Ended June 30, 2025
GlobeNewswire
·
August 8, 2025
FARGO, N.D., Aug. 08, 2025 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (NASDAQ: NODK) announced today results for the quarter ended June 30, 2025. Summary of Second Quarter 2025 Results – Continuing Operations (All comparisons vs. continuing operations for the …
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
GlobeNewswire
·
August 8, 2025
Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through engineered CD55 membrane expression; IND …
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of PepGen Inc.(PEPG) Shareholders
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) - September 15, 2025 Deadline to Join – Contact Levi & Korsinsky
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Westwood Holdings Group, Inc. Reports Second Quarter 2025 Results
GlobeNewswire
·
August 8, 2025
Assets Under Management totaled $18.3 billion, up from $16.8 billion last year WHG joined the Russell 2000 Index in our 24th Year as a Public Company Enhanced Midstream Energy ETF (MDST) surpassed $100 million with a 10.2% p.a. Distribution Rate WEBs …
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
GlobeNewswire
·
August 8, 2025
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea U.S. Commercialization Officially Launched Mont-Saint-Guibert, Belgium – August 8, 2025, 10:10pm CET / 4:10pm ET – …
Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil
GlobeNewswire
·
August 8, 2025
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil Lancement Officiel de la Commercialisation aux États-Unis Mont-Saint-Guibert, …
September 26, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SOC
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Contact Levi & Korsinsky by September 16, 2025 Deadline to Join Class Action Against Neogen Corporation (NEOG)
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 8, 2025
Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development Surrozen forms Clinical Advisory Board comprised of leading retinal specialists Data Presentations at Association for Research in Vision and Ophthalmology Annual Meeting and …
Monroe Capital Corporation Schedules Second Quarter 2025 Earnings Release
GlobeNewswire
·
August 8, 2025
CHICAGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its second quarter ended June 30, 2025 financial results on Monday, August 11, 2025, after the close of the financial …
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
August 8, 2025
– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepdegestrant is the first PROteolysis TArgeting Chimera ( …
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 8, 2025
BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options …
Femasys Announces Second Quarter Financial Results for 2025
GlobeNewswire
·
August 8, 2025
-- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio -- ATLANTA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth …